跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-SOLIFENACIN SUCCINATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-SOLIFENACIN SUCCINATE
Authorized
STANDARD
M-SOLIFENACIN SUCCINATE
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
510638530afa6048
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
510638530afa6048
Drug Approval Canada Name
M-SOLIFENACIN SUCCINATE
Product Name
M-SOLIFENACIN SUCCINATE
Status
Marketed
Status Date
2023-08-18
Original Market Date
2023-08-18
Din
02529696
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
86:12.04
Atc Original
G04BD08 SOLIFENACIN
Atc Name
g 04 bd 08
Aig Number
0151584001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
SOLIFENACIN SUCCINATE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
510638530afa6048
Type
Standard
Back to Health Canada Approvals